Literature DB >> 22366659

Enhancement of rostral ventrolateral medulla neuronal nitric-oxide synthase-nitric-oxide signaling mediates the central cannabinoid receptor 1-evoked pressor response in conscious rats.

Badr Mostafa Ibrahim1, Abdel A Abdel-Rahman.   

Abstract

Our recent studies implicated brainstem GABAergic signaling in the central cannabinoid receptor 1 (CB(1)R)-mediated pressor response in conscious rats. Given the well established link between neuronal nitric-oxide synthase (nNOS)/nitric oxide (NO) signaling and GABAergic transmission in brainstem cardiovascular regulating areas, we elucidated the role of nNOS-generated NO in the central CB(1)R-elicited pressor response. Compared with vehicle, intracisternal (i.c.) microinjection of the CB(1)R agonist (R)-(+)-[2,3-dihydro-5-methyl-3[(4-morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl) methanone mesylate (WIN55212-2) (15 μg/rat) significantly enhanced nNOS phosphorylation as well as the total nitrate and nitrite content in the rostral ventrolateral medulla (RVLM) at 5, 10, and 30 min, which paralleled the elicited pressor response. These findings were corroborated by: 1) the parallel dose-related increases in blood pressure and RVLM-NO levels, measured in real time by in vivo electrochemistry, elicited by intra-RVLM WIN55212-2 (100, 200, or 300 pmol /80 nl; n = 5) in conscious rats; and 2) the significantly higher phosphorylated nNOS (p-nNOS) levels in the WIN55212-2-injected RVLM compared with the contralateral RVLM. Subsequent neurochemical studies showed that WIN55212-2 (15 μg/rat i.c.) significantly increased the number and percentage of neurons immunostained for nNOS (nitroxidergic neurons) and c-Fos (marker of neuronal activity) within the RVLM. The increases in blood pressure and the neurochemical responses elicited by intracisternal WIN55212-2 were attenuated by prior central CB(1)R blockade by N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (AM251; 30 μg/rat i.c.) or selective nNOS inhibition by N(ω)-propyl-(L)-arginine (1 μg/rat i.c.). These findings implicate RVLM p-nNOS/NO signaling as a molecular mechanism in the central CB(1)R-evoked pressor effect in conscious rats.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22366659      PMCID: PMC3362886          DOI: 10.1124/jpet.112.192369

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  31 in total

1.  o-Phenylenediamine-modified carbon fiber electrodes for the detection of nitric oxide.

Authors:  M N Friedemann; S W Robinson; G A Gerhardt
Journal:  Anal Chem       Date:  1996-08-01       Impact factor: 6.986

2.  Overexpression of eNOS in the RVLM causes hypotension and bradycardia via GABA release.

Authors:  T Kishi; Y Hirooka; K Sakai; H Shigematsu; H Shimokawa; A Takeshita
Journal:  Hypertension       Date:  2001-10       Impact factor: 10.190

3.  Differential modulation of brainstem phosphatidylinositol 3-kinase/Akt and extracellular signal-regulated kinase 1/2 signaling underlies WIN55,212-2 centrally mediated pressor response in conscious rats.

Authors:  Badr Mostafa Ibrahim; Abdel A Abdel-Rahman
Journal:  J Pharmacol Exp Ther       Date:  2011-09-26       Impact factor: 4.030

4.  Cannabinoids cause central sympathoexcitation and bradycardia in rabbits.

Authors:  N Niederhoffer; B Szabo
Journal:  J Pharmacol Exp Ther       Date:  2000-08       Impact factor: 4.030

5.  Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation.

Authors:  N Niederhoffer; B Szabo
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

6.  Differential engagements of glutamate and GABA receptors in cardiovascular actions of endogenous nNOS or iNOS at rostral ventrolateral medulla of rats.

Authors:  Samuel H H Chan; Ling-Lin Wang; Julie Y H Chan
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

7.  Cannabinoid receptor activation in the rostral ventrolateral medulla oblongata evokes cardiorespiratory effects in anaesthetised rats.

Authors:  James R Padley; Qun Li; Paul M Pilowsky; Ann K Goodchild
Journal:  Br J Pharmacol       Date:  2003-08-04       Impact factor: 8.739

8.  Differential contributions of NOS isoforms in the rostral ventrolateral medulla to cardiovascular responses associated with mevinphos intoxication in the rat.

Authors:  J Y H Chan; S H H Chan; A Y W Chang
Journal:  Neuropharmacology       Date:  2004-06       Impact factor: 5.250

9.  Central effects of the cannabinoid receptor agonist WIN55212-2 on respiratory and cardiovascular regulation in anaesthetised rats.

Authors:  Torsten Pfitzer; Nathalie Niederhoffer; Bela Szabo
Journal:  Br J Pharmacol       Date:  2004-06-28       Impact factor: 8.739

10.  Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: autonomic nervous mechanisms.

Authors:  N L Benowitz; J Rosenberg; W Rogers; J Bachman; R T Jones
Journal:  Clin Pharmacol Ther       Date:  1979-04       Impact factor: 6.875

View more
  13 in total

Review 1.  Implicating the potential role of orexin in hypertension.

Authors:  Monika Rani; Raghuvansh Kumar; Pawan Krishan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-05-16       Impact factor: 3.000

2.  Central GPR109A Activation Mediates Glutamate-Dependent Pressor Response in Conscious Rats.

Authors:  Samar Rezq; Abdel A Abdel-Rahman
Journal:  J Pharmacol Exp Ther       Date:  2015-11-30       Impact factor: 4.030

3.  A pivotal role for enhanced brainstem Orexin receptor 1 signaling in the central cannabinoid receptor 1-mediated pressor response in conscious rats.

Authors:  Badr Mostafa Ibrahim; Abdel A Abdel-Rahman
Journal:  Brain Res       Date:  2015-06-18       Impact factor: 3.252

4.  Exercise training augments neuronal nitric oxide synthase dimerization in the paraventricular nucleus of rats with chronic heart failure.

Authors:  Neeru M Sharma; Xuefei Liu; Tamra L Llewellyn; Kenichi Katsurada; Kaushik P Patel
Journal:  Nitric Oxide       Date:  2019-03-13       Impact factor: 4.427

5.  Estrogen dampens central cannabinoid receptor 1-mediated neuroexcitation and pressor response in conscious female rats.

Authors:  Fanrong Yao; Abdel A Abdel-Rahman
Journal:  Biochem Pharmacol       Date:  2022-05-23       Impact factor: 6.100

6.  Rostral Ventrolateral Medulla EP3 Receptor Mediates the Sympathoexcitatory and Pressor Effects of Prostaglandin E2 in Conscious Rats.

Authors:  Samar Rezq; Abdel A Abdel-Rahman
Journal:  J Pharmacol Exp Ther       Date:  2016-08-29       Impact factor: 4.030

7.  The novel endocannabinoid receptor GPR18 is expressed in the rostral ventrolateral medulla and exerts tonic restraining influence on blood pressure.

Authors:  Anusha Penumarti; Abdel A Abdel-Rahman
Journal:  J Pharmacol Exp Ther       Date:  2014-01-15       Impact factor: 4.030

8.  Neuronal nitric oxide synthase-dependent elevation in adiponectin in the rostral ventrolateral medulla underlies g protein-coupled receptor 18-mediated hypotension in conscious rats.

Authors:  Anusha Penumarti; Abdel A Abdel-Rahman
Journal:  J Pharmacol Exp Ther       Date:  2014-08-06       Impact factor: 4.030

Review 9.  Cannabinoid receptor 1 signaling in cardiovascular regulating nuclei in the brainstem: A review.

Authors:  Badr M Ibrahim; Abdel A Abdel-Rahman
Journal:  J Adv Res       Date:  2013-04-03       Impact factor: 10.479

Review 10.  Brain stem adenosine receptors modulate centrally mediated hypotensive responses in conscious rats: A review.

Authors:  Noha N Nassar; Abdel A Abdel-Rahman
Journal:  J Adv Res       Date:  2014-12-18       Impact factor: 10.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.